ArkBio’s New Drug Application for ADHD Therapeutic Azstarys Accepted and Granted Priority Review by China NMPA
SHANGHAI, June 16, 2025 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio")…
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 13, 2025 16:01 ET | Source: Nurix Therapeutics, Inc. SAN FRANCISCO,…
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 09, 2025 16:05 ET | Source: Vera Therapeutics BRISBANE, Calif., June…
TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
June 06, 2025 16:05 ET | Source: TELA Bio, Inc. MALVERN, Pa.,…
Press Release: Rilzabrutinib granted orphan drug designation in the US for sickle cell disease
Rilzabrutinib granted orphan drug designation in the US for sickle cell disease…
Protolabs Announces Inducement Awards Under NYSE Rule 303A.08
MINNEAPOLIS--(BUSINESS WIRE)--Proto Labs, Inc. ("Protolabs" or the "Company") (NYSE: PRLB), the world’s…
4DMT Announces New Employment Inducement Grants
EMERYVILLE, Calif., May 16, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq:…
HashKey Group Announces Launch of HashKey Global MENA with VASP License in UAE
HONG KONG, May 12, 2025 /PRNewswire/ -- HashKey Group ("HashKey"), a leading…
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CLEVELAND, May 07, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO)…
Open nominations for the BIAL Award in Biomedicine 2025 with an increased amount to 350,000
Created to distinguish the most remarkable scientific discoveries in the biomedical field, this…